Contact this trialFirst, we need to learn more about you.
Small Molecule Inhibitor
BI 1810631 for Advanced Cancer
Recruiting1 awardPhase 1
Nashville, Tennessee
This trial is testing a new drug, BI 1810631, to see if it can help people with advanced cancer who have not responded to other treatments. The first part of the study will test different doses of the drug to see what the highest dose the participants can tolerate is. The second part will test whether the drug can make tumours shrink.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.